Geron Corp

-$0.01 (-0.8%)
Closing price February 21, 2020

4 Companies That Destroyed Shareholders Last Week

The August doldrums are seemingly over. We hit a new high for the markets and now we have taken a big step back. There are a fair number of questions ...
Read Full Story »

Kroger, Whole Foods in Monday’s 52-Week Low Club

September 12, 2016: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in Monday's session. NYSE advancers led decliners by more than 2 ...
Read Full Story »

Is Geron Being Overly Punished?

Geron Corp. (NASDAQ: GERN) has never been a stock without controversy. That controversy used to revolve around stem cells, but now it is a controversial stock for another reason. Investors ...
Read Full Story »

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

Investors have had a hard time in May. Biotech investors also have faced some hard decisions going into the 2016 elections, where both sides of the aisle seem more than willing ...
Read Full Story »

Can Geron Shares Still Ultimately Double?

Many investors are enthralled with stocks that have massive upside potential. It turns out that many of the companies that are said can double are in the biotech sector, and to say ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Stocks bounced on Thursday, but Friday's early trading indications were looking for a sharp sell-off of almost 2%, based on more oil and China weakness. This is also ahead of ...
Read Full Story »

4 Ignored Biotech Stocks for 2016

Biotech gets a lot of sustained attention, but some stocks still fall through the cracks, either due to recent failures or general lack of interest. Here are four that don’t ...
Read Full Story »

Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks

On the close Tuesday, the PowerShares Dynamic exchange traded funds (ETFs) are set for a rebalance. What this means is the 15 individual ETFs in the Dynamic family will be ...
Read Full Story »

What Licensing Imetelstat Will Mean for Geron

Geron Corp. (NASDAQ: GERN) has announced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize imetelstat. What investors need to keep ...
Read Full Story »

Is Geron Back From the Dead?

The U.S. Food and Drug Administration (FDA) gave Geron Corp. (NASDAQ: GERN) some good news Monday morning when it removed the clinical hold on the company’s investigational new drug application ...
Read Full Story »

Nasdaq Falls Below 4,000 on Biotech, Technology Weakness

Since the beginning of the year, the Nasdaq Composite Index has given up more than 4% of its value, dropping from a high of around 4,357 in early March to ...
Read Full Story »
stock symbol ticker

The 5 Stocks That Dominated the Market on Tuesday

March 18, 2014: Markets opened higher on Tuesday and the number buyers rose throughout the day. There was something of a Vladimir Putin rally today following Russia’s formal annexation of ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Dominated the Market on Wednesday

March 12, 2014: Markets opened lower on Wednesday following a so-so trading day in Europe. Crude oil pulled back 2% after the EIA’s inventory report indicated a larger inventory gain ...
Read Full Story »

Back to Normalcy at Geron

Geron Corp. (NASDAQ: GERN) is getting a reality check on Wednesday. After a recovery from years of disappointment, this is starting to feel again like the Geron that everyone knew ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Celgene, Goldman, Geron and More

Stocks are looking for direction after the first week of a sell-off on the heels of eight weeks of a rally. At the same time, investors are getting ready for ...
Read Full Story »